Researchers Say COVID-19 Pandemic Did Not Interrupt Treatment For Patients with HIV During Trials Assessing Long-Acting ART

Healio (10/26, N. Dreisbach) reports researchers concluded that the COVID-19 pandemic did not interrupt treatment for patients with HIV “during the numerous global trials assessing long-acting cabotegravir and rilpivirine for ART.” The findings were prese...